• Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: U.S.

iShares Nasdaq Biotechnology ETF

+ Add to Watchlist

IBB:US

317.2000 USD 3.2300 1.03%

As of 20:10:00 ET on 12/19/2014.

Snapshot for iShares Nasdaq Biotechnology ETF (IBB)

Open: 314.6100 High - Low: 319.1400 - 310.8730 Primary Exchange: NASDAQ GM
Volume: 2,018,849 52-Week Range: 207.4800 - 319.1400 Beta vs XNBI: 1.0000

ETF Chart for IBB

No chart data available.
  • IBB:US 317.2000
  • 1D
  • 1M
  • 1Y
313.9700
Interactive IBB Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for IBB

iShares Nasdaq Biotechnology ETF is an exchange-traded fund incorporated in the USA. The Fund's objective seeks investment results that correspond to the performance of the Nasdaq Biotechnology Index. The Fund will concentrate its investments in companies primarily engaged in using biomedical research for the discovery or development of new treatments or cures for human disease.

Inception Date: 2001-02-09 Telephone: 1-415-670-2000
Managers: GREG SAVAGE / RENE CASIS
Web Site: www.ishares.com

Fundamentals for IBB

NAV (on 2014-12-19) 316.7200
Assets (M) (on 2014-12-19) 7,284.5190
Shares out (M) 23.00
Market Cap (M) 7,295.60
% Premium 0.15
Average 52-Week % Premium 0.0091
Fund Leveraged N

Dividends for IBB

Dividend Type Income
Dividend Frequency Quarter
Last Dividend Net -
Dividend Yield (ttm) 0.14%

Performance for IBB

1-Month +7.81% 1-Year +45.76%
3-Month +15.27% 3-Year +47.21%
Year To Date +39.94% 5-Year +32.23%
Expense Ratio 0.48

Top Fund Holdings for IBB

Filing Date: 12/18/2014
Name Position Value % of Total
Celgene Corp 5,229,600 609,143,808 8.694%
Amgen Inc 3,565,205 600,665,738 8.573%
Regeneron Pharmaceuticals Inc 1,232,551 522,342,788 7.455%
Biogen Idec Inc 1,448,606 512,371,942 7.312%
Gilead Sciences Inc 4,619,138 487,503,825 6.958%
Vertex Pharmaceuticals Inc 2,655,478 312,655,980 4.462%
Mylan Inc/PA 5,086,017 289,038,346 4.125%
Alexion Pharmaceuticals Inc 1,467,759 277,347,741 3.958%
Illumina Inc 1,385,351 259,462,389 3.703%
BioMarin Pharmaceutical Inc 2,000,535 183,709,129 2.622%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil